GLP-1 drugs, such as Ozempic and Wegovy, may slightly increase the risk of osteoporosis, gout, and the rare metabolic bone disease osteomalacia, a recent study suggests.
As these conditions are all related to bones and joints, the study’s…
Continue Reading
News Source: www.sciencealert.com

Leave a Reply